A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential
about
Breast cancer stem cells: Multiple capacities in tumor metastasis.Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas.Follicular dendritic cells in health and disease.Cancer stem cells and their role in metastasisCanine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applicationsDynamic Interactions Between Cancer Stem Cells And Their Stromal Partners.A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma.Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells.Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.Hide-and-seek: the interplay between cancer stem cells and the immune system.Regulation of expression of ABCB1 and LRP genes by mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and its role in generation of side population cells in canine lymphoma cell lines.The hypoxia signalling pathway in haematological malignancies.Overview of Cancer Stem Cells and Stemness for Community Oncologists.Inhibition of FAK kinase activity preferentially targets cancer stem cellsCancer stem cell and stromal microenvironmentA patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis
P2860
Q34257303-59EF9B33-1846-4472-839C-5716853A797BQ35178103-44E9741D-030D-4CAF-ABA1-D9FA0733EC4DQ36250237-41BF8F15-6014-44A0-81F0-42524FCBCDF0Q36698757-BE779AA9-A604-447D-93D1-1BA1366C7F8BQ37196999-3DF98836-D73B-4D44-84B0-168941804F5AQ37641700-6C22F810-206E-46C6-91A2-385F5FB0E2F6Q37709719-652B3023-92C8-40C8-B806-52FF458441D6Q38132359-24559319-C3A4-46D5-A713-54340B181993Q38814109-F888BC6A-8325-416C-9002-F192AD285E2AQ38954118-DA246832-BE00-461C-B0BE-F05F780543A1Q39014465-54190809-2507-41F5-8306-B18A52BB97B8Q39241807-235C0062-2821-4846-BFA0-BD00D0F776C5Q39246376-72B67385-E2C8-40E5-8DC3-FF79F5FBE6B1Q39406329-0323732E-D24C-4089-B45F-6BF9CE5BD56BQ41612992-55D43578-BD89-4336-99F1-91510A71041CQ42540118-47232FEA-171E-413D-B92E-C9C41CF8B98CQ57167683-42BF1310-A1CE-4470-AACD-DB0AF7399BE9
P2860
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A rare fraction of drug-resist ...... aintain tumourigenic potential
@ast
A rare fraction of drug-resist ...... aintain tumourigenic potential
@en
type
label
A rare fraction of drug-resist ...... aintain tumourigenic potential
@ast
A rare fraction of drug-resist ...... aintain tumourigenic potential
@en
prefLabel
A rare fraction of drug-resist ...... aintain tumourigenic potential
@ast
A rare fraction of drug-resist ...... aintain tumourigenic potential
@en
P2093
P2860
P1476
A rare fraction of drug-resist ...... aintain tumourigenic potential
@en
P2093
Chelsea Grimes
Chung-Gi Lee
Lillian Yau
Tracey Lavezzi
P2860
P356
10.1111/J.1365-2141.2012.09123.X
P407
P50
P577
2012-04-18T00:00:00Z